Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 44
- 试验地点
- 1
- 主要终点
- markers of endothelial activation, coagulation and inflammation
研究概览
简要总结
Diabetes is a major public health problem. Hispanics/Latinos are known to be at higher risk for type 2 diabetes. The function of the endothelium has played a key role in the understanding of vascular complications in people with diabetes. Endothelial function and vascular reactivity are impaired not only in white adults with type 2 diabetes but also in those at risk for the disease by virtue of having impaired glucose tolerance or parental history of type 2 diabetes. Whether this finding is applicable to hispanics is not known. The investigators plan to assess the endothelial function and vascular reactivity in young Hispanic adults at risk of developing type 2 diabetes by virtue of being obese and belonging to a minority population.
研究设计
- 研究类型
- Observational
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age between 18-40 years;
- •Hispanic (we will consider a subject being Hispanic if both parents are reported as Hispanics when asked the following question: "What ethnic group do you consider that you belong to?");
- •History of type 2 diabetes in one or both parents;
- •BMI above 27;
- •Not have participated in any exercise program for the 6 months prior to the beginning of the study.
- •Age between 18-40 years;
- •Hispanic (same criteria as above );
- •No history of type 2 diabetes in any first degree relative;
- •BMI under 25;
- •Not have participated in any exercise program for the 6 months prior to the beginning of the study.
排除标准
- •diabetes, glucose intolerance, pregnancy, smoking, cardiovascular disease, uncontrolled hypertension, renal disease, proteinuria, cancer, infectious diseases, severe GI diseases, lung disease, electrolyte abnormalities, anemia, endocrine disorders, severe dyslipidemia, peripheral vascular disease, medications: beta-blockers, any diuretic, calcium channel blockers, ACE inhibitors, angiotensin receptor blockers, niacin, glucocorticoids, any antineoplastic agent, antibiotics, psychoactive agents, bronchodilators or insulin.
结局指标
主要结局
markers of endothelial activation, coagulation and inflammation
时间窗: cross sectional evaluation
次要结局
未报告次要终点
研究者
Enrique Caballero
Clinical Investigator/Director, Latino Diabetes Initiative
Joslin Diabetes Center